Australian Clinical Labs Limited (ACL.AX)
AUD 3.49
(-3.32%)
AUD 3.49
(-3.32%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 247.36 Million AUD | -56.3% |
| 2023 | 566.02 Million AUD | -27.59% |
| 2022 | 781.7 Million AUD | 49.83% |
| 2021 | 521.72 Million AUD | 513.5% |
| 2020 | 85.04 Million AUD | -35.57% |
| 2019 | 131.99 Million AUD | 19.73% |
| 2018 | 110.24 Million AUD | -60.92% |
| 2017 | 282.08 Million AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 60.42 Million AUD | 2.49% |
| 2024 FY | 138.45 Million AUD | -75.54% |
| 2024 Q3 | 68.04 Million AUD | 12.61% |
| 2024 Q1 | 58.95 Million AUD | -16.66% |
| 2024 Q4 | 68.04 Million AUD | 0.0% |
| 2023 Q4 | 70.74 Million AUD | 16.45% |
| 2023 FY | 566.02 Million AUD | -27.59% |
| 2023 Q3 | 60.74 Million AUD | -24.16% |
| 2023 Q1 | 64.46 Million AUD | -50.63% |
| 2023 Q2 | 80.1 Million AUD | 24.25% |
| 2022 Q2 | 237.32 Million AUD | 72.6% |
| 2022 Q1 | 137.49 Million AUD | 43.74% |
| 2022 FY | 781.7 Million AUD | 49.83% |
| 2022 Q4 | 130.58 Million AUD | 50.42% |
| 2022 Q3 | 86.81 Million AUD | -63.42% |
| 2021 FY | 521.72 Million AUD | 513.5% |
| 2021 Q3 | 66.27 Million AUD | -29.28% |
| 2021 Q2 | 93.72 Million AUD | 48.61% |
| 2021 Q4 | 95.65 Million AUD | 44.32% |
| 2021 Q1 | 63.06 Million AUD | 37.79% |
| 2020 Q2 | 41.24 Million AUD | 10.88% |
| 2020 FY | 85.04 Million AUD | -35.57% |
| 2020 Q4 | 45.77 Million AUD | 36.74% |
| 2020 Q3 | 33.47 Million AUD | -18.85% |
| 2020 Q1 | 37.2 Million AUD | 0.0% |
| 2019 FY | 131.99 Million AUD | 19.73% |
| 2018 FY | 110.24 Million AUD | -60.92% |
| 2017 FY | 282.08 Million AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| BCAL Diagnostics Limited | 3.09 Million AUD | -7884.251% |
| Genetic Signatures Limited | -16.2 Million AUD | 1626.819% |
| Genetic Technologies Limited | 3.9 Million AUD | -6235.296% |
| Healius Limited | 541.2 Million AUD | 54.294% |
| Imagion Biosystems Limited | -3.88 Million AUD | 6470.144% |
| Integral Diagnostics Limited | 103.8 Million AUD | -138.298% |
| INOVIQ Ltd | -989.82 Thousand AUD | 25090.352% |
| Microba Life Sciences Limited | -8.58 Million AUD | 2982.244% |
| Monash IVF Group Limited | 85.5 Million AUD | -189.31% |
| Rhythm Biosciences Limited | -1.35 Million AUD | 18323.449% |
| Sonic Healthcare Limited | 2.33 Billion AUD | 89.385% |